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Abstract 
Objective: The present study evaluated the effects on gestation, in terms of oxidative stress, of two antioxidant factors- 
vitamin E and coenzyme Q10- during pregnancy, with the purpose of applying the results in further human clinical practice.  
Methods: For each aspect we have studied, we used three types of female rats of Wistar race (un-pregnant, primiparous, 
multiparous), divided in 10 rats/group. From the blood we have sampled, we have determined the oxidative stress (OS) markers: 
malondialdehyde (MDA) and carbonylated proteins (CP), but also the markers of the antioxidant defense: the hydrogen donor 
capacity of the plasma (HD) and the sulfhydryl groups (SH).  
Results: Vitamin E administration determines significant decreases of MDA and significant increases of CP and HD at 
primiparous, and also significant increases of SH groups at multiparous. In the case of pregnant animals that received CoQ10 in 
antioxidant complexes, we have observed an increase of oxidative stress (OS)- MDA in primiparous and CP in multiparous.  
Conclusions: In the case of Vitamin E, taking into account the benefits on redox homeostasis, the decrease of OS, the 
authors recommend vitamin E administration during pregnancy. However, because of the increase of the OS in the case of pregnant 
animals, the authors do not recommend the administration of CoQ10 in antioxidant complexes during pregnancy.   
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Introduction 
People are exposed to many carcinogens and 
the most important seem to be reactive oxygen species 
(ROS) and reactive nitrogen species (RNS). Formation of 
reactive oxygen species (ROS) and reactive nitrogen 
species (RNS) in the human body can cause oxidative 
damage to biological macromolecules such as DNA, lipids 
and proteins that may contribute to many diseases 
(cancer, cardiovascular and neurological diseases, etc). 
To counteract the prooxidant actions in the human body, 
an intricate network of antioxidants (AO) is operative in 
biological systems [1].  
In a healthy body, there is a balance between 
ROS, RNS and AO. In normal pregnancies, the 
production of free radicals and lipoperoxidation increase 
towards the end of the pregnancy, as compared to 
unpregnant women. In the same time, the antioxidant 
capacity gradually increases during the pregnancy, 
leading to an oxidative balance that is maintained 
throughout the pregnancy [2]. On the other hand, a lack of 
balance between free radicals and antioxidants leads to 
oxidative stress. 
The human diet provides a range of different 
compounds that possess antioxidant activities or have 
been suggested to scavenge ROS/RNS based on their 
structural properties. The most prominent representatives 
of dietary antioxidants are ascorbate (vitamin C), 
tocopherols (vitamin E), carotenoids and flavonoids [1]. 
Observational epidemiological studies clearly show a 
correlation between the increased consumption of food 
rich in antioxidants and a decreased risk of several 
oxidative stress related disease [3].  Protective effects of 
antioxidants have been found in animal studies [4], as 
well as in epidemiological studies [5] and in some small-
scale intervention studies [6].  
Objective 
The presence of ROS and RNS into the female 
genital tract and the data concerning the modifications of 
the oxidants/antioxidants balance during normal and 
pathologic pregnancy determined us to experimentally 
study the effects of some antioxidant factors- vitamin E Journal of Medicine and Life Vol. 4, No. 2, April‐June 2011 
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and coenzyme Q10 on pregnancy, with the purpose of 
applying the results in further clinical practice.  
The genetic resemblance between mice and 
humans and the reduced pregnancy duration (20-21 
days) determined us to choose this species for 
experimental research on gestation.  
Materials and methods 
We used three types of female rats of Wistar 
race (10 weeks un-pregnant, 12 weeks primiparous, over 
12 weeks multiparous) for each aspect we have studied, 
divided in 10 rats/group. From the blood we have sampled 
on the 21st – 22nd gestation day, we have determined the 
oxidative stress markers: malondialdehyde (MDA) and 
carbonylated proteins (CP), but also the markers of the 
antioxidant defense:  the hydrogen donor capacity (HD) of 
the plasma and the sulfhydryl groups (SH).  
The results were compared to those we have 
obtained in control groups (unpreagnant, primiparous and 
multiparous females) that did not receive antioxidant 
factors.  
 
Vitamin E administration 
Vitamin E was administered under the form of 
injectable intramuscular solution 30 mg/ml; it was 
administrated in 4 mg/kg doses  
 
Coenzyme Q10 administration  
Coenzyme Q10 (CoQ10 plus), containing 20 mg 
CoQ10, 1000 U.I. β carotene, 0,21 U.I. α-tocopherol and10 
mg Selenium/cup, was administered in oil-like form by 
oral-pharynges tabulation, in doses of 0,42 mg CoQ10, 22 
U.I.  β carotene, 0,21 U.I. α-tocopherol  şi 0,20 mg 
Selenium/ kg/ animal.  
Results 
Vitamin E administration  
Vitamin E administration determines significant 
decreases of MDA and significant increases of HD in 
unpregnant animals, compared to the control group. In the 
case of primiparous animals, we determined significant 
decreases of MDA and significant increases of CP and 
HD, while in the case of multiparous animals the 
administration determined insignificant modifications of 
the OS markers and significant increases of SH groups.  
As a result, Vitamin E enhances the antioxidant 
capacity, with significant decreases of CP and significant 
increases of SH, in multiparous and primiparous animals.  
Legend for figures 1,2,3,4:  
  Group I:  unpregnant animals  
  Group II: primiparous animals  
  Group III: multiparous animals  
  Group IV: unpregnant animals with vitamin E 
administration  
  Group V: primiparous animals with vitamin E 
administration 
  Group VI: multiparous animals with vitamin E 
administration 
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Fig.1. MDA at groups with/without Vitamin E 
administration: 
Fig.2. CP at groups with/without Vitamin E administration:
Fig. 3. SH at groups with/without Vitamin E administration: Journal of Medicine and Life Vol. 4, No. 2, April‐June 2011 
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CoQ10 administration  
The administration of an antioxidant complex 
determines significant increases of MDA and CP and 
significant increases of HD in unpregnant animals, 
compared to the control group. In the case of primiparous 
animals we determined insignificant modifications of MDA 
and HD and significant increases of CP and SH, and in 
the case of multiparous animals the administration of an 
antioxidant complex determines significant increases of 
MDA and insignificant modifications of CP and antioxidant 
capacity (HD and SH). 
   Legend for figures 5,6,7,8:  
  Group I:  unpregnant animals  
  Group II: primiparous animals  
  Group III: multiparous animals  
  Group VII: unpregnant animals with CoQ10 
administration  
  Group VIII: primiparous animals with CoQ10 
administration 
  Group IX: multiparous animals with CoQ10 
administration 
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Discussions 
Our research aimed to discover the 
consequences of antioxidant administration- Vitamin E 
Fig. 4. HD at groups with/without Vitamin E 
administration: 
Fig. 5. MDA at groups with/without CoQ10 administration: 
Fig. 6. CP at groups with/without CoQ10 administration: 
Fig. 7. SH at groups with/without CoQ10 administration:
Fig. 8. HD at groups with/without CoQ10 administration: Journal of Medicine and Life Vol. 4, No. 2, April‐June 2011 
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and Coenzyme Q10 on pregnant animals, with the purpose 
of applying the results in further human clinical practice.  
Vitamin E is the best antioxidant found in 
membranes, inhibiting the peroxidation of lipids and the 
LDL oxidation; it stabilizes membranes, reduces the 
xathine oxidase and increases the antioxidant effect of 
Se. Its role during pregnancy has not made the object of 
many studies.  
Vitamin E is very important even in prenatal 
period, during the embryonic and fetal development of the 
conception product and continuing with the post-natal 
development of the child [7].  
The recommended daily doses of Vitamin E is of 
22-30 mg/day, quantity considered as sufficient to cover 
the nutrient need of an adult, including pregnant women. 
Vitamin E acts on the lipid membranes in order to prevent 
their oxidation and the forming of free radicals that could 
harm the cellular membranes [8].  
The scientific literature reported that Vitamin E 
could play an important role in preventing: cardiovascular 
diseases and different types of cancer [8], chronic 
inflammations and neurological diseases [9], the 
bronchopulmonary dysplasia of the newborn [10], 
preeclampsia [11, 12, 13, 14]. Other data show that in 
high doses, Vitamin E does not reduce the incidence of 
preeclampsia [15].  
Our results recommend Vitamin E administration 
during pregnancy, taking into account the benefic effects 
on redox homeostasis and the decrease of OS. In the 
case of the administration of AO complexes that contain 
Vitamin E as well the effects are not positive.  
CoQ10, vitamin-like complex, also known as 
vitamin Q10 or ubichinona-10 has the following roles: an 
essential redox transporter within the mitochondrial 
respiratory chain; antioxidant against the lipoperoxidation 
at the level of the internal mitochondrial membrane, the 
cellular membrane and for the low density lipids; favors 
the antioxidant action of Vitamin E; a central role in the 
energetic metabolism; increases the AO activity of vitamin 
C and β-carotene. 
In case of preeclampsia, research has reported 
decreases of the CoQ10  plasmatic levels [16] and 
increases at the placenta level [17].  
The maternal-fetal distribution of CoQ10  can 
increase the risk of oxidative lesions for the newborn [18]. 
The placental increase of CoQ10  in the case of Hellp 
syndrome, a severe complication of preeclampsia, can be 
another compensating mechanism in the case of OS 
increase [19]. The presence of CoQ10  in high 
concentrations in the maternal milk can be directly 
correlated with its AO capacity in different lactation 
stages, in the case of preterm or normal deliveries [20].  
Other data suggest that a rich AO diet- CoQ10  
and Vitamin E before and during pregnancy does not 
decrease the incidence of malformations inducted by the 
administration of phenytoin in female rats [21].  
Our results show the importance of an O/AO 
balance control and they agree with the literature data 
concerning the negative effects of CoQ10  administration 
during pregnancy. Our study observed the increase of OS 
in pregnant animals that received CoQ10. In conclusion, 
the administration of CoQ10  in antioxidant complexes is 
not recommended during pregnancy. The negative effect 
also appears in the case of AO complexes composed of 
CoQ10, Se, α-tocopherol and β-carotene. 
Conclusions 
Our research brings experimental proofs 
regarding the effect on redox homeostasis of some 
antioxidant factors during pregnancy (Vitamin E and 
CoQ10 administration); our study agrees with the 
scientific literature that determined the consequences of 
these factors on human pregnancy.  
In the case of Vitamin E, taking into account the 
positive effects on redox homeostasis, with the decrease 
of OS, the authors recommend the Vitamin E 
administration during pregnancy. On the other hand, 
because of the increase of the OS in the case of pregnant 
animals, the authors do not recommend the 
administration of CoQ10 in antioxidant complexes during 
pregnancy.   
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